Jeevan Scientific Reports No Fund Utilization Deviation Q1 FY27

Key Quantitative Figures

• Fund Raising Mode: Preferential Allotment
• Instrument Type: Equity
• Date of Fund Raising: January 2, 2026
• Amount Raised: ₹30.74 crore (3074 Lakhs)
• Reporting Quarter: Ended June 30, 2026

Fund Utilization Details

No deviation or variation in the utilization of proceeds from the preferential allotment was reported for the quarter ended June 30, 2026.

Original Fund Allocation and Utilization (in ₹ Lakhs):

1. Capital Expenditure:

• Original Allocation: 500.00
• Funds Utilized: 414.46

2. Working Capital Requirement:

• Original Allocation: 350.00
• Funds Utilized: 279.97

3. Working Capital & Capital Expenditure for Subsidiary:

• Original Allocation: 500.00
• Funds Utilized: 300.53

4. Acquisition of API/formulation unit(s):

• Original Allocation: 1000.00
• Funds Utilized: 300.00

Regulatory and Governance Review

• Monitoring Agency: Not applicable
• Audit Committee Comments: NIL (after review)
• Auditor Comments: NIL
• Shareholder Approval: Not applicable (no deviation)

Financial Impact

No financial impact from deviation or variation reported as the company confirmed utilization as per original objects. The disclosure is a compliance statement without material financial changes.